This inventor holds 1 USPTO granted patent. Top assignee: Zentiva, A.s.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Dagmar Jasprova: Innovator in Pharmaceutical Patents
Introduction
Dagmar Jasprova is a notable inventor based in Prague, Czech Republic. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative tablet formulations. Her work exemplifies the intersection of science and practical application in medicine.
Latest Patents
Dagmar holds a patent for a tablet obtained by direct compression, which comprises 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid as the active ingredient. This tablet is designed to contain the active ingredient in an amount ranging from 5 to 140 mg, based on the pure acid. The formulation includes a dry binder, a disintegrating agent, a lubricant, and utilizes a combination of at least two diluents, excluding lactose, as the diluent.
Career Highlights
Dagmar Jasprova is associated with Zentiva, a.s., where she applies her expertise in pharmaceutical development. Her innovative approach to tablet formulation has the potential to enhance the efficacy and patient compliance of medications.
Collaborations
[Section skipped due to space constraints.]
Conclusion
Dagmar Jasprova's contributions to pharmaceutical innovations highlight her role as a leading inventor in her field. Her patent for a novel tablet formulation demonstrates her commitment to advancing medical science and improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile